Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Merck Group
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===2000 to 2009=== On 13 March 2006, Merck announced a takeover bid for [[Schering AG]], the world's largest producer of oral contraceptives. On 23 March 2006, [[Bayer]] AG made a supported offer for Schering and Merck decided to drop out of the bidding for the company.<ref>{{Cite web |title=Übernahme: Schering rät zur Annahme der Bayer-Offerte|url=https://www.manager-magazin.de/finanzen/artikel/a-411895.html|language=de|website=Manager Magazin|date=19 April 2006|access-date=6 July 2023}}</ref> Schering is not to be confused with [[Schering-Plough]] which was once part of Schering AG but was acquired by Merck & Co. in 2009. In September 2006 the company announced a takeover bid of $13.2 billion for [[Serono]] SA, Switzerland's largest biotech firm. The deal included a buy-out of the [[Ernesto Bertarelli|Bertarelli]] family's 64.5% stake in Serono to be followed by a public tender offer for the remaining shares starting in November 2006.<ref>{{Cite web |title=Serono-Übernahme: Mercks Milliardendeal|url=https://www.manager-magazin.de/unternehmen/artikel/a-438324.html|language=de|website=Manager Magazin|date=21 September 2006|access-date=6 July 2023}}</ref><ref>{{Cite web|title=Merck KGaA to acquire Serono|url=http://www.firstwordpharma.com/node/135767|date=21 September 2006|access-date=10 February 2023|website=FirstWord Pharma|archive-url=https://web.archive.org/web/20160822215354/http://www.firstwordpharma.com/node/135767|archive-date=22 August 2016}}</ref> The combined company has an R&D budget of approximately $1.1 billion and sales of approximately $4.6 billion. Its approximately $2 billion in sales of [[biologic medical product|biologics]] would make it seventh among pharmaceutical/biotech companies. The new entity, [[Merck Serono]], began operations in 2007. Merck KGaA established its philanthropic foundation in 2008 called Merck Foundation. [[Rasha Kelej]] currently serves as its CEO.<ref>{{cite news |title=New Merck Foundation appoints Rasha Kelej |url=http://www.pmlive.com/pharma_appointments/the_merck_foundation_appoints_rasha_kelej_1197271 |work=PMLive |date=28 June 2017 |language=en}}</ref><ref>{{cite news |title=Rasha Kelej Becomes Merck Foundation CEO |url=https://businesspost.ng/jobs/rasha-kelej-becomes-merck-foundation-ceo/ |work=Business Post Nigeria |date=26 June 2017}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)